checkAd
    Cerevel Therapeutics Holdings Aktie
    41,77
     
    USD
    -0,67 %
    -0,28 USD
    Letzter Kurs 21.05.24 Nasdaq
    41,75
     
    USD
    20.900 STK
    Geldkurs 21.05.24
    41,77
     
    USD
    4.900 STK
    Briefkurs 21.05.24
    ISIN: US15678U1280 · WKN: A2QF3L · SYM: CERE · USA

    Neueste Nachrichten

    Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
    18.04.24 · globenewswire · Cerevel Therapeutics Holdings
    CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders
    08.01.24 · Business Wire (engl.) · Cerevel Therapeutics Holdings
    CEREVEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
    08.12.23 · Business Wire (engl.) · Cerevel Therapeutics Holdings
    CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders
    07.12.23 · Business Wire (engl.) · Cerevel Therapeutics Holdings
    Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease
    29.11.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics to Present at Upcoming Investor Conferences
    08.11.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
    01.11.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023
    13.10.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock
    12.10.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
    11.10.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
    29.08.23 · globenewswire · Cerevel Therapeutics Holdings
    Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
    02.08.23 · globenewswire · Cerevel Therapeutics Holdings